Getting a simple at-home test for colon cancer shouldn't depend on your zip code. But a new review of global screening programs suggests it might. The analysis pooled data from dozens of studies on the FIT test, which checks for hidden blood in stool. It found that where people live is linked to whether they take the test, but the pattern isn't the same everywhere. In Europe, people in rural areas were slightly more likely to participate than those in cities. In Australia, the opposite was true—people in remote areas were less likely to take part compared to those in metropolitan regions. The good news is that for those who did the test, the chance of a positive result—which signals a need for a follow-up colonoscopy—was the same regardless of location. This means the test itself works equally well everywhere. It's important to remember this data comes from observing existing screening programs; it doesn't prove that geography causes the difference in participation. The studies were also varied, making it hard to pin down a single reason for the gap. The takeaway is clear: we need to understand these geographical barriers better to make sure everyone has a fair shot at early cancer detection.
Meta-analysis finds geographical disparities in FIT-based colorectal cancer screening participationWhere you live may affect your chance of getting screened for colon cancer
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note geographical disparities in FIT screening participation, but interpret as observational association.
This systematic review and meta-analysis examined geographical disparities in participation and positivity rates for fecal immunochemical test (FIT)-based colorectal cancer screening. The analysis included 35 studies (with 21 used for meta-analysis) involving average-risk individuals aged 40-74. The comparator was geographical location, specifically rural/remote versus urban/metropolitan areas.
The overall pooled FIT participation rate was 49.9% (95% CI: 40.6, 59.2). The analysis revealed geographical disparities: in Europe, participation was higher in rural areas compared to urban areas (pooled odds ratio [POR]: 1.20; 95% CI: 1.01, 1.42). Conversely, in Australia, participation was lower in remote areas compared to metropolitan areas (POR: 0.75; 95% CI: 0.65, 0.87). The overall pooled FIT positivity rate was 8.70% (95% CI: 6.50, 11.70), and there was no statistically significant difference in positivity rates between rural and urban settings (p = 0.24).
Safety and tolerability data were not reported. Key limitations, including study heterogeneity and potential confounding factors, were not detailed in the provided evidence. The findings are based on observational data pooled in a meta-analysis, which establishes association but not causation. The practice relevance of these findings is that they highlight variable geographical patterns in screening uptake, but the underlying mechanisms for these disparities and their generalizability to all regions remain unclear.
What this means for you:
Your address shouldn't decide your access to cancer screening. More on Cancer
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Fibromyalgia as an oncology comorbidity increases symptom burden and impairs treatment adherence
Fibromyalgia makes managing cancer pain more difficult for patients
This systematic review of 11 studies examines fibromyalgia as a comorbidity in cancer patients. The findings indicate that fibromyalgia cont…
Patients with both fibromyalgia and cancer face higher symptom burdens and may stop life-saving treatments sooner due to intense, amplified …
Comprehensive palliative care improves quality of life, survival, and symptoms in thoracic cancer patients
Palliative care improves quality of life for thoracic cancer patients
This meta-analysis of 6490 people with thoracic cancer found that comprehensive palliative care interventions improved quality of life (SMD …
Comprehensive palliative care can improve survival, manage symptoms, and boost quality of life for people living with thoracic cancers.
Long-read sequencing improves detection of structural variants and methylation patterns in liquid biopsy
Long-read sequencing improves detection of cancer signals in blood
This mini-review examines the application of long-read sequencing (LRS) for liquid biopsy, specifically focusing on cfDNA and ctDNA. The aut…
Newer long-read sequencing technology helps doctors identify complex genetic changes and the source of tumors in lung, brain, and pediatric …
View Original Abstract ↓
BACKGROUND: People in rural and remote areas often participate less actively in colorectal cancer (CRC) prevention practices, including faecal immunochemical testing (FIT). However, the evidence on this is limited.
OBJECTIVE: The aim of this systematic review and meta-analysis was to summarise geographical disparities in participation and positivity of FIT-based CRC screening.
METHODS: Six databases were searched for articles published until June 2024. We included studies reporting FIT-based CRC screening among average-risk individuals aged 40-74, examining geographical disparities using location-based or geospatial methods. Two reviewers independently screened, assessed bias, and extracted data. Random-effects models estimated pooled participation, positivity rates, and odds ratios for geographical effects.
RESULTS: Of 8532 articles, 35 were included in the review, with 21 used for meta-analysis. The overall FIT participation rate was 49.9% (95% confidence interval [CI]: 40.6, 59.2). In Europe, individuals in rural areas had higher participation rates compared to urban areas (pooled odds ratio [POR]: 1.20; 95% CI: 1.01, 1.42), while in Australia, remote areas exhibited lower odds of participation than metropolitan areas (POR: 0.75; 95% CI: 0.65, 0.87). The overall FIT positivity rate was 8.70% (95% CI: 6.50, 11.70), with no significant difference between rural and urban areas (p = 0.24).
CONCLUSIONS: A notable disparity in the FIT-based CRC screening participation rate was observed using the geographical definition of rurality and remoteness. Further research is needed to identify the sociocultural, healthcare access, and policy factors driving these differences and develop targeted strategies to improve screening and address barriers for underserved populations.
Experimental agents show response rates up to 70% in relapsed or refractory diffuse large B-cell lymphoma
New cancer therapies double response rates for tough lymphoma
Related in Oncology
Sacubitril/Valsartan preserves left ventricular systolic function and attenuates GLS deterioration during chemotherapy
Sacubitril and Valsartan May Protect Heart Function During Chemotherapy
This meta-analysis of randomized controlled trials evaluates sacubitril/valsartan for patients undergoing chemotherapy to manage chemotherap…
A new review suggests the medication sacubitril/valsartan may help preserve heart muscle function for patients undergoing chemotherapy.
DaVinci Single-Port transoral robotic surgery is feasible across multiple indications including oncology and sleep apnea
Single-Port Robot Shows Promise for Sleep Apnea Surgery
This systematic review and meta-analysis of 479 patients evaluates the feasibility of DaVinci Single-Port (SP) transoral robotic surgery (TO…
A new analysis finds single-port robotic surgery for sleep apnea is feasible, with short operating times and low blood loss.
Neoadjuvant chemoimmunotherapy achieves higher pathological complete response rates than chemotherapy alone in muscle-invasive bladder cancer
Chemoimmunotherapy Shows Higher Response Rates in Bladder Cancer
This network meta-analysis of 2234 patients with muscle-invasive bladder cancer compares neoadjuvant chemoimmunotherapy (NICT), chemotherapy…
A new analysis shows that combining chemotherapy and immunotherapy may lead to higher response rates for patients with muscle-invasive bladd…
MRI Radiomics Predicts TERTp Mutation in Glioma with Moderate Accuracy
MRI Radiomics Help Predict TERTp Mutation in Glioma Patients
Meta-analysis of 14 studies shows MRI radiomics predicts TERTp mutation in glioma with AUC 0.79; combined models improve accuracy to 0.82.
New analysis shows MRI-based radiomics can help predict specific genetic mutations in glioma, potentially aiding early diagnosis and treatme…
From Other Specialties
Post-extubation dysphagia incidence ranges from 28.36% to 68.94% in critically ill children
High rates of swallowing problems found in children after intubation
This scoping review of 15 studies examines the incidence and predictors of pediatric post-extubation dysphagia (PED). The authors identify h…
Many critically ill children struggle to swallow safely after breathing tubes are removed, with some studies showing issues in up to 69% of …
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …